Diabetic FootNCT06000371
Cutoff Value of Ankle Brachial Pressure Index for Vacuum Assisted Closure Application in Diabetic Foot Ulcers
An observational study of Diabetic Foot, run by Mansoura University at 1 site in Egypt.
Trial summary
Abstract Objective To verify cutoff value of ankle brachial pressure index at which diabetic foot ulcers get benefit from vacuum assisted closure application and to assess impact of its application on ankle brachial pressure index value in the presence of peripheral arterial disease. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Diabetic Foot
- What is being tested?
- Vacuum assisted Closure application
- Type of treatment
- Medical device
- How many people
- 56 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Apr 2020to 2 Oct 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patient ≥40 years with unhealed diabetic foot ulcers belonged to grade 1 or grade 2 (in both wound and infection categories of WIFI classification) .
Who may be able to join
- Patient ≥40 years.
- Unhealed diabetic foot ulcers.
- Ulcers belonged to grade 1 or grade 2 (in both wound and infection categories "WIFI" classification) .
Who cannot join
- Immunocompromised patients.
- Patient with varicose veins and chronic venous insufficiency.
- Foot ulcers belonged to grade 3 (in both wound and infection categories of WIFI classification)
Trial locations and contacts
1 site in 1 country.
About this study
Abstract Objective To verify cutoff value of ankle brachial pressure index at which diabetic foot ulcers get benefit from vacuum assisted closure application and to assess impact of its application on ankle brachial pressure index value in the presence of peripheral arterial disease.
Methods An observational descriptive prospective analytic study had been performed.56 patients were enrolled in the study. All patients had three sessions of vacuum-assisted closure application. Debridement was done when indicated. Ulcer dimensions were measured before and after each session, while ankle brachial pressure index was measured before the first session .
Read the detailed description
Introduction Diabetes Mellitus (DM) is a chronic disease, which is considered a global public health problem that leads to major clinical, economic, social, and quality of patient life issues (1). 15% of diabetics will develop a diabetic foot ulcer (DFU) during their lifetime, which is an exceedingly expensive and disabling complication of diabetes mellitus. (2).
Assessment of foot perfusion is a crucial step in treatment of patients with DFU. The ankle-brachial pressure index (ABPI) is a simple, quick, non-invasive tool (3). The key elements of effective DFU management are clinical awareness, appropriate blood glucose levels, regular foot exams, therapeutic footwear that fits the patient, off-loading, local wound care, and the identification and treatment of osteomyelitis and ischemia (4).
Multiple adjuvant therapies have been studied to decrease DFU healing times and amputation rates. These therapies include negative pressure wound therapy (vacuum-assisted closure), non-surgical debridement agents, oxygen therapies, human growth factors, energy based therapies, and systemic therapies(5).Cellular and/ or tissue based product (CTPs) may result in higher average number of ulcer free months and lower average number of amputations and resections compared to standard of care (SOC) alone (6).
Negative pressure wound therapy (NPWT) is a non-invasive therapy that removes fluid from wounds, prepares the wound bed for closure, reduces edema, and promotes the creation and perfusion of granulation tissue by applying regulated negative pressure using a vacuum-assisted closure (VAC) device (7). NPWT is indicated in traumatic, acute wounds, sub-acute wounds (i.e. dehisced incisions), chronic open wounds (stasis ulcers and diabetic ulcers), pressure ulcers, flaps and meshed graft (8).
We conducted this this study to verify cutoff value of ABPI at which diabetic foot ulcers get benefit from VAC application.
Methods A single-center prospective observational study had been performed. Between March 2020 and May 2021, 56 patients with DFUs underwent VAC application in the Department of Vascular Surgery. The inclusion criteria consisted of the following: the patient ≥40 years with unhealed diabetic foot ulcers belonged to grade 1 or grade 2 (in both wound and infection categories of wound, ischemia and wound infection " WIFI classification) . Patients with immunocompromised status, varicose veins, chronic venous insuffiency, foot ulcers belonged to grade 3 (in both wound and infection categories of WIFI classification) . All patients who were involved in the study gave their written consent.
The patients were subjected to history taking including history of foot ulceration, amputation, symptoms of claudication, neurologic changes, vascular surgery and medical comorbidities. The site, shape, base and margins of the ulcer had been clinically examined. The clinical manifestations of infection including erythema, warmth, swelling, pain or tenderness were searched for. Proper neurological and vascular examination had been applied to all included feet. The following investigations were done: duplex U/S on arterial system (for all patients), X-ray (in case of suspected infected collections or osteomyelitis) and CT angiography (when duplex is inconclusive).
Procedure description:
Prior to VAC application, ABPI was measured and documented with using of Bistos hi dop vascular Doppler with 8MHZ probe (Bistos Co., Ltd. Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea) and mercurial sphygmomanometer (ALPK2, 300v velcro cuff, Japan) according to the procedure described by the American College of Cardiology (ACC) and the American Heart Association (AHA) guidelines (9) and ulcer was prepared by debridement of devitalized tissue, proper hemostasis and wound irrigation with saline .
Then, length, width and depth of the ulcer were measured by metal ruler and documented. The ulcer was gently filled with foam, ensuring that the foam was slightly above the ulcer edge. The drain was placed between foam layers. The drape was sized and trimmed to cover the entire ulcer as well as about 3-5 cm of intact skin around it. The drape shouldn't be stretched or under tension. Adhesive plaster was used at edges to maintain sealing and negative suction .
The dressing drain was attached to canister tube with opening the clamp. The suction pressure was adjusted at-120 mmHg with intermittent mode. If the patient experienced bleeding despite good hemostasis or pain that was not relieved by analgesics, pressure can be reduced by 10mmHg. Power button was pressed to turn on Smith\& Nephew Renesys EZ plus NPWT device (Smith \& Nephew Medical Ltd. Hull HU3 2BN, England. The patient was informed about steps of disconnection and maximum period of disconnection 2hours /day. Patient or his/her relative was informed about causes of alarm e.g. low pressure, full canister, line blockage and low battery and how to manage them.
- Conditions
- Diabetic Foot
- Being tested
- Vacuum assisted Closure application
- Medical subject headings
- Diabetic Foot
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vacuum assisted Closure applicationDevice
Vacuum assisted Closure Application in Diabetic Foot Ulcers
What is being measured
The primary outcome is the main question the study is designed to answer.
Dimensions of diabetic foot ulcer (manual measurement of length, width and depth of the ulcer by metal ruler).
Change of dimensions of diabetic foot ulcers. The higher values mean a worse outcome.
Measured: Up to3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2023
- Study start25 Apr 2020
- Primary completion1 May 2021
- Study completion2 Oct 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Diabetic FootStudies of the same condition, open and under way.
- More trials run by Mansoura UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Mansoura university, Principal investigator, MU
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06000371
- Sponsor's protocol ID
- MS.20.03.1083
- Status last verified
- Aug 2023
- First submitted
- 31 Jul 2023
- Last updated
- 21 Aug 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Undecided
Publications
1. Bonoto BC, de Araújo VE, Godói IP, de Lemos LLP, Godman B, Bennie M, et al. Efficacy of mobile apps to support the care of patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. JMIR mHealth and uHealth. 2017;5(3):e4. 2. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World journal of diabetes. 2015;6(1):37. 3. Hajibandeh S, Hajibandeh S, Shah S, Child E, Antoniou GA, Torella F. Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular. 2017;25(2):208-24. 4. Mavrogenis AF, Megaloikonomos PD, Antoniadou T, Igoumenou VG, Panagopoulos GN, Dimopoulos L, et al. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT open reviews. 2018;3(9):513-25. 5. Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018;1411(1):153. 6. Serena TE, Yaakov RA, Mostow EN. Use of Cellular and Tissue-based Product in the Treatment of Diabetic Foot Ulcers. The Journal of Foot and Ankle Surgery (Asia-Pacific). 2016;3(2):92-6. 7. Lone AM, Zaroo MI, Laway BA, Pala NA, Bashir SA, Rasool A. Vacuum-assisted closure versus conventional dressings in the management of diabetic foot ulcers: a prospective case-control study. Diabetic foot & ankle. 2014;5(1):23345. 8. Yadav S, Rawal G, Baxi M. Vacuum assisted closure technique: a short review. The Pan African Medical Journal. 2017;28. 9. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909.
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cutoff Value of Ankle Brachial Pressure Index for Vacuum Assisted Closure Application in Diabetic Foot Ulcers
- ClinicalTrials.gov ID
- NCT06000371
- Acronym / sponsor ID
- MS.20.03.1083
- Conditions
- Diabetic Foot
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 25 Apr 2020 (actual)
- Primary completion
- 1 May 2021 (actual)
- Study completion
- 2 Oct 2021 (actual)
- First posted
- 21 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Abstract Objective To verify cutoff value of ankle brachial pressure index at which diabetic foot ulcers get benefit from vacuum assisted closure application and to assess impact of its application on ankle brachial pressure index value in the presence of peripheral arterial disease.
Methods An observational descriptive prospective analytic study had been performed.56 patients were enrolled in the study. All patients had three sessions of vacuum-assisted closure application. Debridement was done when indicated. Ulcer dimensions were measured before and after each session, while ankle brachial pressure index was measured before the first session .
Detailed description
Introduction Diabetes Mellitus (DM) is a chronic disease, which is considered a global public health problem that leads to major clinical, economic, social, and quality of patient life issues (1). 15% of diabetics will develop a diabetic foot ulcer (DFU) during their lifetime, which is an exceedingly expensive and disabling complication of diabetes mellitus. (2).
Assessment of foot perfusion is a crucial step in treatment of patients with DFU. The ankle-brachial pressure index (ABPI) is a simple, quick, non-invasive tool (3). The key elements of effective DFU management are clinical awareness, appropriate blood glucose levels, regular foot exams, therapeutic footwear that fits the patient, off-loading, local wound care, and the identification and treatment of osteomyelitis and ischemia (4).
Multiple adjuvant therapies have been studied to decrease DFU healing times and amputation rates. These therapies include negative pressure wound therapy (vacuum-assisted closure), non-surgical debridement agents, oxygen therapies, human growth factors, energy based therapies, and systemic therapies(5).Cellular and/ or tissue based product (CTPs) may result in higher average number of ulcer free months and lower average number of amputations and resections compared to standard of care (SOC) alone (6).
Negative pressure wound therapy (NPWT) is a non-invasive therapy that removes fluid from wounds, prepares the wound bed for closure, reduces edema, and promotes the creation and perfusion of granulation tissue by applying regulated negative pressure using a vacuum-assisted closure (VAC) device (7). NPWT is indicated in traumatic, acute wounds, sub-acute wounds (i.e. dehisced incisions), chronic open wounds (stasis ulcers and diabetic ulcers), pressure ulcers, flaps and meshed graft (8).
We conducted this this study to verify cutoff value of ABPI at which diabetic foot ulcers get benefit from VAC application.
Methods A single-center prospective observational study had been performed. Between March 2020 and May 2021, 56 patients with DFUs underwent VAC application in the Department of Vascular Surgery. The inclusion criteria consisted of the following: the patient ≥40 years with unhealed diabetic foot ulcers belonged to grade 1 or grade 2 (in both wound and infection categories of wound, ischemia and wound infection " WIFI classification) . Patients with immunocompromised status, varicose veins, chronic venous insuffiency, foot ulcers belonged to grade 3 (in both wound and infection categories of WIFI classification) . All patients who were involved in the study gave their written consent.
The patients were subjected to history taking including history of foot ulceration, amputation, symptoms of claudication, neurologic changes, vascular surgery and medical comorbidities. The site, shape, base and margins of the ulcer had been clinically examined. The clinical manifestations of infection including erythema, warmth, swelling, pain or tenderness were searched for. Proper neurological and vascular examination had been applied to all included feet. The following investigations were done: duplex U/S on arterial system (for all patients), X-ray (in case of suspected infected collections or osteomyelitis) and CT angiography (when duplex is inconclusive).
Procedure description:
Prior to VAC application, ABPI was measured and documented with using of Bistos hi dop vascular Doppler with 8MHZ probe (Bistos Co., Ltd. Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea) and mercurial sphygmomanometer (ALPK2, 300v velcro cuff, Japan) according to the procedure described by the American College of Cardiology (ACC) and the American Heart Association (AHA) guidelines (9) and ulcer was prepared by debridement of devitalized tissue, proper hemostasis and wound irrigation with saline .
Then, length, width and depth of the ulcer were measured by metal ruler and documented. The ulcer was gently filled with foam, ensuring that the foam was slightly above the ulcer edge. The drain was placed between foam layers. The drape was sized and trimmed to cover the entire ulcer as well as about 3-5 cm of intact skin around it. The drape shouldn't be stretched or under tension. Adhesive plaster was used at edges to maintain sealing and negative suction .
The dressing drain was attached to canister tube with opening the clamp. The suction pressure was adjusted at-120 mmHg with intermittent mode. If the patient experienced bleeding despite good hemostasis or pain that was not relieved by analgesics, pressure can be reduced by 10mmHg. Power button was pressed to turn on Smith\& Nephew Renesys EZ plus NPWT device (Smith \& Nephew Medical Ltd. Hull HU3 2BN, England. The patient was informed about steps of disconnection and maximum period of disconnection 2hours /day. Patient or his/her relative was informed about causes of alarm e.g. low pressure, full canister, line blockage and low battery and how to manage them.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patient ≥40 years with unhealed diabetic foot ulcers belonged to grade 1 or grade 2 (in both wound and infection categories of WIFI classification) .
Key inclusion criteria (3 listed)
- Patient ≥40 years.
- Unhealed diabetic foot ulcers.
- Ulcers belonged to grade 1 or grade 2 (in both wound and infection categories "WIFI" classification) .
Key exclusion criteria (3 listed)
- Immunocompromised patients.
- Patient with varicose veins and chronic venous insufficiency.
- Foot ulcers belonged to grade 3 (in both wound and infection categories of WIFI classification)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vacuum assisted Closure applicationVacuum assisted Closure Application in Diabetic Foot Ulcers | Device | – |
Primary outcome
Dimensions of diabetic foot ulcer (manual measurement of length, width and depth of the ulcer by metal ruler).
Time frame: Up to3 weeks
Change of dimensions of diabetic foot ulcers. The higher values mean a worse outcome.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2023.
- Background1. Bonoto BC, de Araújo VE, Godói IP, de Lemos LLP, Godman B, Bennie M, et al. Efficacy of mobile apps to support the care of patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. JMIR mHealth and uHealth. 2017;5(3):e4. 2. Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World journal of diabetes. 2015;6(1):37. 3. Hajibandeh S, Hajibandeh S, Shah S, Child E, Antoniou GA, Torella F. Prognostic significance of ankle brachial pressure index: a systematic review and meta-analysis. Vascular. 2017;25(2):208-24. 4. Mavrogenis AF, Megaloikonomos PD, Antoniadou T, Igoumenou VG, Panagopoulos GN, Dimopoulos L, et al. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT open reviews. 2018;3(9):513-25. 5. Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018;1411(1):153. 6. Serena TE, Yaakov RA, Mostow EN. Use of Cellular and Tissue-based Product in the Treatment of Diabetic Foot Ulcers. The Journal of Foot and Ankle Surgery (Asia-Pacific). 2016;3(2):92-6. 7. Lone AM, Zaroo MI, Laway BA, Pala NA, Bashir SA, Rasool A. Vacuum-assisted closure versus conventional dressings in the management of diabetic foot ulcers: a prospective case-control study. Diabetic foot & ankle. 2014;5(1):23345. 8. Yadav S, Rawal G, Baxi M. Vacuum assisted closure technique: a short review. The Pan African Medical Journal. 2017;28. 9. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-909.
- Individual participant dataSharing planned: Undecided
Related trials for Diabetic Foot
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Active, not recruiting
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Diabetes, Peripheral Neuropathy
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Not yet recruiting
Efficacy Evaluation of Turmeric-Derived Nanoparticle Hydrogel for the Treatment of Diabetic Foot Ulcer Wounds
Diabete Mellitus
Not yet recruiting
Better Care Closer to Home: Enhancing Primary and Community Care
Diabetic Foot Disease, Recurrence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mansoura university principal investigator
MU
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetic Foot, run by Mansoura University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dimensions of diabetic foot ulcer (manual measurement of length, width and depth of the ulcer by metal ruler). (time frame: Up to3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06000371, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.